Klinische studie tandheelkundige implantaten levert 10-jarige uitkomsten

11 december 2012 - Grote klinische studie van tandheelkundige implantaten levert indrukwekkende 10-jarige uitkomsten. Hieronder treft u de originele tekst van het persbericht aan.

New research findings have just been published from one of the largest long-term clinical studies on the survival and success of dental implants. 

The study, which was conducted at the University of Bern in Switzerland, assessed the outcome of 511 Straumann SLA tissue-level implants in 303 patients over 10 years.

Its authors concluded: “The present retrospective analysis resulted in a 10-year implant survival rate of 98.8% and a success rate of 97.0%. In addition, the prevalence of peri-implantitis in this large cohort of orally healthy patients was low with 1.8% during the 10-year period”. No implant fracture was noted.

The importance of this study lies not only in the impressive long-term outcomes but also in the fact that it is one of the first large 10-year clinical studies to document a dental implant of this kind that is still on the market. The Straumann SLA tissue-level implant is indeed one of the most extensively studied dental implants and these long-term results explain why it is also one of the most widely used. 

For details please see the release from the University of Bern and the full publication:   
At: http://onlinelibrary.wiley.com/doi/10.1111/j.1708-8208.2012.00456.x/full

About Straumann
Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs more than 2500 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.